SUDOSCAN has been presented for the first time at the AACE conference (American Association of Clinical Endocrinologists) in Phoenix, AR, from May 1-5, 2013.

Two posters were presented:

Assessment of small nerve neuropathy through a quick, simple and non invasive method in a diabetes outpatient consult clinic by Schwarz et al.

Sudomotor function assessment as a screening tool for microvascular complications in type 2 diabetes by Santosh et al.


SUDOSCAN has been highlighted by Healio, an online Medical News journal, as an efficicent test for diabetic neuropathy detection:


Sudoscan test efficiently detected diabetic neuropathy

PHOENIX — A recently FDA-approved device is proving to be a promising method for detecting neuropathy in patients with diabetes. The non-invasive Sudoscan test, which measures sweat glands in order to detect levels of neuropathy, can be performed in the clinical setting and completed within just a few minutes with no special patient or equipment preparation, according to data presented here at the AACE Annual Scientific and Clinical Congress.

According to Aaron I. Vinik, MD, PhD, professor of medicine and director of research at the neuroendocrine unit at Eastern Virginia Medical School, there are 96,000 amputations that occur every year as a result of neuropathy. Overall, “there is an 11-fold increase in fall and fracture rate. In patients over the age of 65 with a combination of diabetes and aging, there’s a 15-fold increase in falling and fracture. The problem is the physicians aren’t examining patients [for neuropathy]. Even if they do, they aren’t giving proper advice,” Vinik said during a press conference.”

Read the full article


Close Menu